MPR rolls out revamped website

Share this article:
Monthly Prescribing Reference (MPR) has relaunched its website with a number of enhancements to functionality and design, as well as a new, easier-to-remember URL, www.eMPR.com.

The new site will continue to focus on drug information but now offers a beefed-up search capability that can filter information according to a number of different criteria, including relevance, therapeutic category and date.
Furthermore, accompanying each drug monograph is a series of related resource options, such as drug news, sponsored alerts, pharmacology notes, clinical charts, similar drugs and recent updates to the data. Also, users are now able to compare drugs, side by side.

The redesigned site is easier to navigate and now features links to related sites, such as www.myCME.com. It also offers a much wider range of options for sponsors.

Physicians have been using the print editions of MPR for more than 25 years, and Jim Pantaleo, MPR vice president and publisher, says the new site is part of an initiative to offer up-to-date, concise drug information to healthcare professionals during every part of their day and in the medium of their choice.

MPR is published by Prescribing Reference, Inc., part of Haymarket Media, which also publishes MM&M.
Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.